Cabos-Siguier Béatrice, Steunou Anne-Lise, Joseph Gérard, Alazard Robert, Ducoux-Petit Manuelle, Nieto Laurence, Monsarrat Bernard, Erard Monique, Clottes Eric
Group Interactions acides nucléiques/protéines comme cibles pharmacologiques, Université de Toulouse UPS/CNRS-IPBS (Institut de Pharmacologie et Biologie Structurale), Toulouse, France.
Protein Expr Purif. 2009 Mar;64(1):39-46. doi: 10.1016/j.pep.2008.10.009. Epub 2008 Oct 25.
This report describes the first purification procedure of the human full-length N Oct-3 protein in amounts suitable for structural studies and proteomic investigations. N Oct-3 is a transcription factor member of the POU protein family. It possesses a large N-terminal transactivation domain and a DNA-binding domain (DBD) which is composed of two subdomains, POUs and POUh, which are joined by a linker peptide. N Oct-3 is a master gene for central nervous system development but also for melanoma progression. Previous structural studies have all been performed using N Oct-3 DBD only. In this study, the full-length N Oct-3 protein was bacterially expressed and purified to homogeneity. The purified protein gave a single band at approximately 53 kDa on SDS-PAGE, while cDNA sequence analysis revealed a calculated molecular mass of 47 kDa confirmed by mass spectroscopy. Size-exclusion chromatography experiments indicated that in solution, full-length N Oct-3 was a monomer. Circular dichroïsm and intrinsic tryptophan fluorescence showed that full-length N Oct-3 was folded, with a significant alpha-helix content probably located in its DBD. Comparison with the purified N Oct-3 DBD demonstrated that, at least in vitro, the affinity of the protein for its DNA targets was similar. This suggests that the transactivation domain of N Oct-3 was not involved in N Oct-3 DNA interaction.